Financial leverage has increased significantly, with total debt rising to $99.3M by 2025Q4, while net PPE now accounts for $180.5M of the company's $282.8M in total assets.
| Total Current Assets | 89.13M | 57.3M | 89.15M | 116.15M | 162.22M | 144.03M | 41.4M | 7.85M | 1.85M | 3.11M | 1.7M | 6.42K |
| Cash & Short-Term Investments | 84.12M | 42.56M | 78.63M | 99.04M | 142.74M | 136.66M | 38.81M | 6.05M | 396.22K | 2.42M | 1.67M | 10 |
| Cash Only | 84.12M | 42.56M | 78.71M | 99.04M | 142.74M | 136.66M | 38.81M | 6.05M | 396.22K | 2.42M | 1.67M | 10 |
| Short-Term Investments | 0 | 0 | 702.87K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.12M | 8.16M | 3.56M | 2.85M | 2.45M | 2.04M | 1.23M | 478.4K | 595.91K | 289.99K | 38.76K | 6.41K |
| Days Sales Outstanding | 137.41 | 508.63 | 161.52 | 277.38 | 146.72 | 142.65 | 108.48 | 96.1 | 100.15 | 1.31K | 700.61 | - |
| Inventory | 2.18M | 1.38M | 2M | 3.17M | 1.87M | 2.78M | 1.37M | 1.12M | 646.14K | 318.69K | 0 | 0 |
| Days Inventory Outstanding | 26.58 | 285.3 | 259.22 | 47.51 | 396.23 | 119.32 | 412.57 | 122.05 | 85.18 | 82.75 | - | - |
| Other Current Assets | 3 | 3.5M | 3.34M | 9.14M | 10.09M | 2.27M | 0 | 204.71K | 215.3K | 88.34K | 0 | 0 |
| Total Non-Current Assets | 193.7M | 168.8M | 174.19M | 161.28M | 140.76M | 58.83M | 33.85M | 27.07M | 35.2M | 32.39M | 1.22M | 100.75K |
| Property, Plant & Equipment | 180.48M | 155.67M | 144.28M | 89M | 111.56M | 38.99M | 12.47M | 5.98M | 2.44M | 12.81M | 16.96K | 0 |
| Fixed Asset Turnover | 0.03x | 0.04x | 0.06x | 0.04x | 0.05x | 0.13x | 0.33x | 0.30x | 0.89x | 0.01x | 1.19x | - |
| Goodwill | 11.97M | 11.98M | 11.98M | 8.18M | 11.98M | 15.95M | 17.41M | 17.04M | 4.55M | 4.42M | 0 | 0 |
| Intangible Assets | 0 | 0 | 10.41K | 8.32M | 389.75K | 16.58M | 18.37M | 18.23M | 5.03M | 531.27K | 0 | 0 |
| Long-Term Investments | 0 | 0 | 16.63M | 11.27M | 16.67M | 0 | 0 | 7.67M | 11.64M | 13.09M | 0 | 0 |
| Other Non-Current Assets | 1.24M | 1.16M | 1.25M | 52.69M | 168.71K | -12.69M | -14.4M | -21.86M | 8.71M | 12.5K | 1.2M | 100.75K |
| Total Assets | 282.83M | 226.1M | 263.34M | 277.42M | 302.98M | 202.86M | 75.26M | 34.92M | 37.05M | 35.5M | 2.92M | 107.17K |
| Asset Turnover | 0.02x | 0.03x | 0.03x | 0.01x | 0.02x | 0.03x | 0.05x | 0.05x | 0.06x | 0.00x | 0.01x | - |
| Asset Growth % | 25.09% | -14.14% | -5.08% | -8.43% | 49.36% | 169.55% | 115.51% | -5.76% | 4.38% | 1113.75% | 2629.08% | - |
| Total Current Liabilities | 83.53M | 46.24M | 37.26M | 8.47M | 7.89M | 5.35M | 3.99M | 6.13M | 973.03K | 13.13M | 211.93K | 111.1K |
| Accounts Payable | 4.28M | 998.26K | 1.34M | 4.11M | 2.65M | 1.83M | 842.18K | 1.31M | 331.79K | 257.82K | 45.24K | 111.1K |
| Days Payables Outstanding | 52.06 | 205.8 | 173.91 | 61.65 | 561.27 | 78.36 | 254.18 | 142.89 | 43.74 | 66.94 | - | - |
| Short-Term Debt | 61M | 30.64M | 28.73M | 114.16K | 119.97K | 277.38K | 273.97K | 4.15M | 86.89K | 9.22M | 0 | 0 |
| Deferred Revenue (Current) | 146.43K | 126.06K | 418K | 71.98K | 2.71K | 310.1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 17.06M | 6.76M | 1.75M | 3.69M | 896.08K | 2.53M | 2.73M | 677.5K | 554.35K | 3.66M | 166.69K | 0 |
| Current Ratio | 1.07x | 1.24x | 2.39x | 13.72x | 20.56x | 26.90x | 10.38x | 1.28x | 1.90x | 0.24x | 8.04x | 0.06x |
| Quick Ratio | 1.04x | 1.21x | 2.34x | 13.35x | 20.32x | 26.38x | 10.04x | 1.10x | 1.24x | 0.21x | 8.04x | 0.06x |
| Cash Conversion Cycle | 111.93 | 588.13 | 246.83 | 263.24 | -18.32 | 183.6 | 266.87 | 75.26 | 141.59 | 1.33K | - | - |
| Total Non-Current Liabilities | 42.2M | 42.26M | 42.15M | 42.9M | 43.96M | 19.33M | 10.94M | 18.25M | 6.9M | 3.95M | 0 | 0 |
| Long-Term Debt | 42.2M | 32.78M | 34.67M | 35.08M | 35.95M | 12.21M | 8.16M | 18.25M | 1.65M | 2.43M | 0 | 0 |
| Capital Lease Obligations | 5.91M | 6.49M | 4.48M | 4.83M | 5.01M | 7.12M | 2.78M | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.83M | 1.52M | 0 | 0 |
| Other Non-Current Liabilities | -5.91M | 0 | 0 | 3M | 5.94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 125.73M | 88.51M | 79.41M | 51.37M | 51.85M | 24.68M | 14.94M | 24.38M | 7.87M | 17.08M | 211.93K | 111.1K |
| Total Debt | 99.27M | 70.42M | 68.22M | 40.37M | 41.41M | 20.01M | 11.35M | 22.39M | 1.73M | 11.64M | 0 | 0 |
| Net Debt | 20.71M | 27.86M | -10.49M | -58.67M | -101.32M | -116.65M | -27.46M | 16.34M | 1.34M | 9.23M | -1.67M | -10 |
| Debt / Equity | 0.63x | 0.51x | 0.37x | 0.27x | 0.16x | 0.11x | 0.19x | 2.12x | 0.06x | 0.63x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | 61.60x | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | 44.94x | - | - | - | - |
| Interest Coverage | -6.83x | -20.00x | -17.24x | -30.31x | -34.31x | -93.07x | -4.21x | -10.54x | -18.23x | -9.46x | - | - |
| Total Equity | 157.1M | 137.59M | 183.94M | 151.39M | 251.13M | 178.18M | 60.31M | 10.54M | 29.18M | 18.41M | 2.71M | -3.93K |
| Equity Growth % | 14.18% | -25.2% | 21.49% | -39.72% | 40.95% | 195.42% | 472.02% | -63.87% | 58.48% | 578.8% | 69163.77% | - |
| Book Value per Share | 0.92 | 1.11 | 1.51 | 1.24 | 2.16 | 1.53 | 0.52 | 0.09 | 0.25 | 0.16 | 0.02 | -0.00 |
| Total Shareholders' Equity | 157.1M | 137.59M | 183.94M | 151.39M | 251.13M | 178.18M | 60.31M | 10.54M | 29.18M | 18.41M | 2.71M | -3.93K |
| Common Stock | 485.32M | 367.54M | 338.43M | 231.06M | 338.01M | 233.2M | 99.85M | 38.16M | 38.16M | 22.21M | 3.95M | 10 |
| Retained Earnings | -352.28M | -259.67M | -184.85M | -94.72M | -110.74M | -81.93M | -63.86M | -43.83M | -17.71M | -7.38M | -1.25M | -3.94K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 24.06M | 29.72M | 30.36M | 15.05M | 23.86M | 26.91M | 24.32M | 16.21M | 8.73M | 3.59M | 11.58K | 10 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital intensive commercialization failure
As reported in recent financial filings, Novonix's equity base has faced significant pressure, declining from $251.1M in 2021Q4 to $157.1M by 2025Q4, a trend that highlights the persistent difficulty in balancing aggressive infrastructure investment with the ongoing operational losses inherent in its current pre-commercial manufacturing phase.
The trajectory of the balance sheet suggests a company increasingly reliant on external capital to bridge the gap between its technological ambitions and commercial reality. Investors should monitor whether the continued expansion of PPE can eventually be supported by internal cash generation, as the current trend indicates a steady depletion of shareholder equity.
Based on the company's reported figures, total debt has climbed from $13.8M in 2021Q2 to $99.3M by 2025Q4, reflecting a strategic, albeit risky, reliance on debt financing to sustain the construction of the Riverside facility while the core business remains unable to generate positive operating cash flow.
The increase in the debt-to-equity ratio to 0.63 suggests that the company is leveraging its balance sheet to survive the long qualification cycles required by Tier-1 battery manufacturers. This debt burden warrants further investigation, as it introduces significant interest rate sensitivity and refinancing risk should the commercialization timeline face further delays.
According to the latest balance sheet data, net PPE has surged to $180.5M in 2025Q4, representing the vast majority of the company's $282.8M in total assets, which underscores the highly capital-intensive nature of the business model and the significant risk of asset impairment if production targets are missed.
The heavy concentration in specialized manufacturing equipment implies that the company's value is almost entirely tied to the successful execution of its continuous furnace technology. If the facility fails to achieve nameplate capacity, the lack of asset liquidity could leave the company with limited options to recover its invested capital.
As indicated by the 2025Q4 current ratio of 1.07, Novonix's liquidity buffer has narrowed significantly from the high levels seen in previous years, suggesting that the company's cash runway is becoming increasingly constrained as it continues to burn through its remaining $84.1M in cash reserves.
The sharp decline in the current ratio from historical highs suggests that the company is operating with a much thinner margin of safety than in prior periods. This liquidity profile may force management to seek additional dilutive financing or government support, which could further impact the long-term value for existing shareholders.
Quick answers to the most common questions about buying NVX stock.
As of 2025, Novonix Limited (NVX) had total assets of $282.8M including $89.1M in current assets.
Novonix Limited (NVX) carries total debt of $99.3M, offset by $84.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Novonix Limited (NVX) has total shareholders' equity (book value) of $157.1M ($0.92 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Novonix Limited (NVX) reported a current ratio of 1.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.